Physician profile
Traci Win Bailey
NPI 1689085912
$2,726.42
in general payments reported to CMS, 2019-2025
16 companies · $747 in 2025
The $747 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.32 · 2022: $733 · 2023: $764 · 2024: $466 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,977.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $768.53 | 2024-2025 | Inspire |
| Medical Device Business Services, INC. | $655.76 | 2022 | |
| Acclarent, INC | $403.69 | 2022-2024 | Trudi Nav Cable |
| Medtronic, INC. | $232.96 | 2023-2025 | Propel, Sinuva |
| Integra Lifesciences Corporation | $169.39 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Ars Pharmaceuticals Operations, INC. | $124.28 | 2025 | Neffy |
| Aerin Medical INC. | $93.96 | 2023-2025 | |
| Kaleo, INC. | $44.82 | 2022-2023 | Auvi-Q |
| Genzyme Corporation | $42.32 | 2022 | |
| Olympus America INC. | $41.17 | 2024 | Rhino-Laryngo Videoscope |
| Hikma Pharmaceuticals USA | $39.21 | 2023 | Ryaltris |
| Takeda Pharmaceuticals U.S.A., INC. | $31.58 | 2023 | Cuvitru |
| Pfizer INC. | $23.07 | 2025 | |
| Optinose US, INC. | $20.87 | 2024 | |
| Merck Sharp & Dohme LLC | $18.49 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $16.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traci Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.